Dysthymia, major depression, and double depression among individuals receiving substance abuse treatment

Naelys Diaz, Eloise Gail Horton, Michael Weiner

Behavioral Health of the Palm Beaches, Inc., North Palm Beach, USA.
Florida Atlantic University, Boca Raton, USA.

DOI: 10.4236/health.2012.412181                

Abstract

The purpose of this study was to compare dysthymia, double depression (DD), and major depressive disorder (MDD) among individuals receiving substance abuse treatment on individual characteristics and mental health factors including age, gender, alcohol and drug dependence, number of previous mental health and substance abuse treatments, number of suicide attempts and attempts under the influence, and perceived quality of life. Out of the 336 medical records reviewed, 41.4% had dysthymia, 4.5% had MDD, and 14% had DD. Results indicated gender differences among those who had dysthymia and MDD, and age differences for those with dysthymia. Mental health factors associated with different mood disorders included alcohol dependence, drug dependence, suicide attempts, suicide attempts under the influence, and quality of life. Implications for the mental health field are discussed, underlining the importance of developing and providing competent treatment for clients with co-occurring disorders.

Keywords

Dysthymia; Mood Disorders; Substance Use Disorders

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Ustun, T.B. and Kessler, R.C. (2002) Global burden of depressive disorders: The issue of duration. British Journal of Psychiatry, 181, 181-183. doi:10.1192/bjp.181.3.181
[2]	Klein, D.N., Schwartz, J.E., Rose, S. and Leader, J.B. (2000) Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study. American Journal of Psychiatry, 157, 931-939. doi:10.1176/appi.ajp.157.6.931
[3]	Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H. and Kendler, K.S. (1994) Lifetime and 12-month prevalence rates of DSM- III-R psychiatric disorders in the United States: Results from the National comorbidity survey. Archives of General Psychiatry, 51, 8-19. doi:10.1001/archpsyc.1994.03950010008002
[4]	Kessler, R.C., Berglund, P., Demler, O., Jin, R. and Walters, E.E. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication. Archives of General Psychiatry, 62, 593-602. doi:10.1001/archpsyc.62.6.593
[5]	Klein, D.N., Dickstein, S., Taylor, E.B. and Harding, K. (1989) Identifying chronic affective disorders in outpatients: Validation of the general behavior inventory. Journal of Consulting and Clinical Psychology, 57, 106-111. doi:10.1037/0022-006X.57.1.106
[6]	American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: Text revision. 4th Edition, Washington DC. doi:10.1176/appi.books.9780890423349
[7]	Klein, D.N., Shankman, S.A. and Rose, S. (2006) Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. American Journal of Psychiatry, 163, 872-880. doi:10.1176/appi.ajp.163.5.872
[8]	Brienza, R.S., Stein, M.D., Chen, M.H., Gogenini, A., Sobota, M., Maksad, J., Hu, P. and Clarke, J. (2000) Depression among needle exchange program and methadone maintenance clients. Journal of Substance Abuse Treatment, 18, 331-337. doi:10.1016/S0740-5472(99)00084-7
[9]	Grant, B.F., Stinson, F.S., Hasin, D.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., Pickering, R.P. and Kaplan, K. (2004) Prevalence and co-occurrence of substance abuse disorders and independent mood disorders and anxiety disorders: Results for the national epidemiologic survey on alcohol and related conditions (NESARC). Archives of General Psychiatry, 61, 807-816. doi:10.1001/archpsyc.61.8.807
[10]	Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, B.J., Judd, L.L. and Goodwin, F.K. (1990) Comorbidity of mental health disorders with alcohol and other drug abuse. Result from the epidemiological catchment area (ECA) Study. Journal of the American Medical Association, 264, 2511-2518. doi:10.1001/jama.1990.03450190043026
[11]	Diaz, N., Horton, G., McIlveen, J., Weiner, M. and Nelson, J. (2009) Dysthymia among substance abusers: An exploratory study of individual and mental health factors. International Journal of Mental Health & Addiction, 7, 357-367. doi:10.1007/s11469-008-9158-0
[12]	Millon, T. (1997) Millon clinical multiaxial inventory-III manual. 2nd Edition, National Computer System, Min- neapolis.
[13]	Craig, R.J. and Olson, R.E. (1998) Stability of the MCMI-III in a substance-abusing inpatient sample. Psychological Report, 83, 1273-1274. doi:10.2466/pr0.1998.83.3f.1273
[14]	Craig, R.J. and Olson, R.E. (2001) Adjective descriptions of personality disorders: A convergent validity study of the MCMI-III. Journal of Personality Assessment, 77, 259-271. doi:10.1207/S15327752JPA7702_09
[15]	Calsyn, D.A., Wells, E.A., Fleming, C. and Saxon, A.J. (2000) Changes in millon clinical multiaxial inventory scores among opiate addicts as a function of retention in methadone maintenance treatment and recent drug use. The American Journal of Drug and Alcohol Abuse, 26, 297-309. doi:10.1081/ADA-100100606
[16]	Teplin, D., O’Connell, T., Daiter, J. and Varenbut, M. (2004) A psychometric study of the prevalence of DSM-IV personality disorders among office-based methadone maintenance patients. The American Journal of Drug and Alcohol Abuse, 30, 515-524. doi:10.1081/ADA-200032270
[17]	Frisch, M. (1994) Quality of life inventory: Manual and treatment guide. National Computer Systems, Minneapolis.
[18]	McAlinden, N.M. and Oei, T.P.S. (2006) Validation of the quality of life inventory for patients with anxiety and depression. Comprehensive Psychiatry, 47, 307-314. doi:10.1016/j.comppsych.2005.09.003
[19]	Bourland, S.L., Stanley, M.A., Snyder, A.G., Novy, D.M., Beck, J.G., Averill, P.M., et al. (2000) Quality of life in older adults with generalized anxiety disorder. Aging and Mental Health, 4, 315-323. doi:10.1080/713649960
[20]	Frisch, M.B., Cornell, J., Villanueva, M. and Retzlaff, P.J. (1992) Clinical validation of the quality of life inventory: A measure of life satisfaction for use in treatment planning and outcome assessment. Psychological Assessment, 4, 92-101. doi:10.1037/1040-3590.4.1.92
[21]	Office of Applied Studies (2004) Results from the 2003 national survey on drug use and health: National findings. Substance Abuse and Mental Health Services Administration, Rockville.
[22]	Kauffman, S.E., Silver, P. and Poulin, J. (1997) Gender differences in attitudes toward alcohol, tobacco, and other drugs. Social Work, 42, 231-241. doi:10.1093/sw/42.3.231
[23]	US Department of Health and Human Services (2000) Gender differences in drug abuse risks and treatment. US Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Rockville.
[24]	Compton, W.M., Cottler, L.B., Abdallah, A.B., Phelps, D.L., Spitznagel, E.L. and Horton, J.C. (2000) Substance dependence and other psychiatric disorders among drug dependent subjects: Race and gender correlates. The American Journal of Addictions, 9, 113-125. doi:10.1080/10550490050173181